24/7 Market News Publishes Report on how Kraig Biocraft's BAM-1 Spider Silk Hybrid Production Affects Spider Silk Market

Company Overview - Kraig Biocraft Laboratories (OTCQB: KBLB) is pioneering the production of genetically bioengineered spider silk using modified silkworms to produce spider silk cocoons in commercial quantities [1][2]. Production Launch - The company has launched the production phase for its BAM-1 recombinant spider silk hybrids, accelerating its 2024 production schedule following successful spring production trials [2][3]. - This production cycle marks the first transition of true production hybrids to the manufacturing environment and represents the largest single batch of spider silk production in the company's history [3]. Management Insights - Kim Thompson, Founder and CEO of Kraig Labs, stated that the successful launch of the BAM-1 hybrids is the result of over a year of focused development, indicating that the company is on track to achieve its first production milestone of one metric ton of spider silk [3].